Author/Creator: Agerberth, B. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Agerberth, B.

1. A3.7 No evidence of cathelicidin being involved in the pathogenesis of lupus and arthritis. (31st January 2014)

Authors:: Kienhoefer, D.; Schubert, I.; Hahn, J.; Bosch, Èlia; Sjöwall, C.; Agerberth, B.; Schett, G.; Hoffmann, M.
Journal:: Annals of the rheumatic diseases
Issue:: Volume 73:Supplement 1(2014)
Page Start:: A44
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0100 Identification of the antimicrobial peptide LL-37 as a potential mediator of synovial inflammation in RA. (23rd January 2014)

Authors:: Neregård, P.; Engström, M.; Lindh, M.; Agerberth, B.; Catrina, A.I.
Journal:: Annals of the rheumatic diseases
Issue:: Volume 71(2012)Supplement 3
Page Start:: 643
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia. (23rd May 2018)

Authors:: Bekele, A.; Gebreselassie, N.; Ashenafi, S.; Kassa, E.; Aseffa, G.; Amogne, W.; Getachew, M.; Aseffa, A.; Worku, A.; Raqib, R.; Agerberth, B.; Hammar, U.; Bergman, P.; Aderaye, G.; Andersson, J.; Brighenti, S.
Journal:: Journal of internal medicine
Issue:: Volume 284:Number 3(2018)
Page Start:: 292
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood. Issue 1 (11th November 2013)

Authors:: Holm, T.; Rutishauser, D.; Kai‐Larsen, Y.; Lyutvinskiy, Y.; Stenius, F.; Zubarev, R. A.; Agerberth, B.; Alm, J.; Scheynius, A.
Journal:: Allergy
Issue:: Volume 69:Issue 1(2014:Jan.)
Page Start:: 104
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. SAT0187 The Antimicrobial Peptide LL-37 and Type I Interferon in Idiopathic Inflammatory Myopathies. (15th July 2016)

Authors:: Lu, X.; Tang, Q.; Lindroos, E.; Lindh, M.; Agerberth, B.; Lundberg, I.; Wick, C.
Journal:: Annals of the rheumatic diseases
Issue:: Volume 75(2016)Supplement 2
Page Start:: 736
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The antimicrobial peptide LL‐37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma. Issue 3 (18th January 2013)

Authors:: Sun, J.; Dahlén, B.; Agerberth, B.; Haeggström, J. Z.
Journal:: Allergy
Issue:: Volume 68:Issue 3(2013:Mar.)
Page Start:: 304
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗